The level of amplification of c-myc in our study ranged between one and four additional copies of the gene; the majority (84%) of the cases with the gene amplification gained only one to two copies, also consistent with FISH data reported for c-myc copy amplification in human metastatic prostate carcinoma tissues (Jenkins et al, 1997). Here, MYC is linked to metastatic prostate carcinoma.